Gti: A novel algorithm for identifying outlier gene expression profiles from integrated microarray datasets

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Mpindi, John Patrick ^a   Sara, Henri ^b   Haapa Paananen, Saija ^c   Kilpinen, Sami ^a   Pisto, Tommi ^c   Bucher, Elmar ^c   Ojala, Kalle ^c   Iljin, Kristiina ^c   Vainio, Paula ^b   Björkman, Mari ^b   Gupta, Santosh ^b   Kohonen, Pekka ^c   Nees, Matthias ^c   Kallioniemi, Olli ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; FLUOROURACIL; GEMCITABINE; RALTITREXED; THYMIDYLATE SYNTHASE;

ARTICLE; ASTROCYTOMA; BIOINFORMATICS; CALCULATION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE TISSUE INDEX; GENETIC ALGORITHM; GENETIC DATABASE; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFORMATION PROCESSING; INFORMATION RETRIEVAL; INTERMETHOD COMPARISON; MICROARRAY ANALYSIS; SIMULATION; STATISTICAL ANALYSIS; ALGORITHM; AUTOMATED PATTERN RECOGNITION; BIOLOGY; BRAIN TUMOR; COMPUTER PROGRAM; EVALUATION; GENETIC ASSOCIATION; GENETICS; METHODOLOGY; STATISTICS; THEORETICAL MODEL; TUMOR CELL CULTURE; VALIDATION STUDY;

ALGORITHMS; ASTROCYTOMA; BRAIN NEOPLASMS; COMPUTATIONAL BIOLOGY; DATA INTERPRETATION, STATISTICAL; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION STUDIES; GLIOBLASTOMA; HUMANS; MICROARRAY ANALYSIS; MODELS, THEORETICAL; PATTERN RECOGNITION, AUTOMATED; SOFTWARE; TUMOR CELLS, CULTURED;

EID: 79951983151     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017259     Document Type: Article

References (30)

1. Callow MJ, Dudoit S, Gong EL, Speed TP, Rubin EM, (2000) Microarray expression profiling identifies genes with altered expression in HDL-deficient mice. Genome Res 10 (12): 2022-2029.
2. Friddle CJ, Koga T, Rubin EM, Bristow J, (2000) Expression profiling reveals distinct sets of genes altered during induction and regression of cardiac hypertrophy. Proc Natl Acad Sci U S A 97 (12): 6745-6750.
3. Johansson Swartling F, (2008) Identifying candidate genes involved in brain tumor formation. Ups J Med Sci 113 (1): 1-38.
4. Spellman PT, Sherlock G, Zhang MQ, Iyer VR, Anders K, et al. (1998) Comprehensive identification of cell cycle-regulated genes of the yeast saccharomyces cerevisiae by microarray hybridization. Mol Biol Cell 9 (12): 3273-3297.
5. Barrett T, Troup DB, Wilhite SE, Ledoux P, Rudnev D, et al. (2009) NCBI GEO: Archive for high-throughput functional genomic data. Nucleic Acids Res 37 (Database issue): D885-90.
6. Lukk M, Kapushesky M, Nikkila J, Parkinson H, Goncalves A, et al. (2010) A global map of human gene expression. Nat Biotechnol 28 (4): 322-324.
7. Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Varambally R, Yu J, et al. (2007) Oncomine 3.0: Genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 9 (2): 166-180.
8. Kilpinen S, Autio R, Ojala K, Iljin K, Bucher E, et al. (2008) Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissues. Genome Biol 9 (9): R139.
9. Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, et al. (2006) The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease. Science 313 (5795): 1929-1935.
10. Elo LL, Lahti L, Skottman H, Kylaniemi M, Lahesmaa R, et al. (2005) Integrating probe-level expression changes across generations of affymetrix arrays. Nucleic Acids Res 33 (22): e193.
11. Bhattacharya S, Mariani TJ, (2005) Transformation of expression intensities across generations of affymetrix microarrays using sequence matching and regression modeling. Nucleic Acids Res 33 (18): e157.
12. Dudoit S, Yang JH, Callow MJ, Speed TP, (2002) Statistical methods for identifying differentially expressed genes in replicated cDNA microarray experiments. Statistica Sinica 12: 111-111-139.
13. Wu B, (2007) Cancer outlier differential gene expression detection. Biostatistics 8 (3): 566-575.
14. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, et al. (2005) Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310 (5748): 644-648.
15. Tibshirani R, Hastie T, (2007) Outlier sums for differential gene expression analysis. Biostatistics 8 (1): 2-8.
16. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, et al. (1987) Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235 (4785): 177-182.
17. Arrow KJ, (1999) Amartya K. sen's contributions to the study of social welfare. In: The Scandinavian Journal of Economics, editors. pp. 163-172.
18. MacDonald JW, Ghosh D, (2006) COPA-cancer outlier profile analysis. Bioinformatics 22 (23): 2950-2951.
19. Liu F, Wu B, (2007) Multi-group cancer outlier differential gene expression detection. Comput Biol Chem 31 (2): 65-71.
20. Li L, Chaudhuri A, Chant J, Tang Z, (2007) PADGE: Analysis of heterogeneous patterns of differential gene expression. Physiol Genomics 32 (1): 154-159.
21. Lian H, (2007) MOST: Detecting cancer differential gene expression. Biostatistics.
22. Eng LF, Rubinstein LJ, (1978) Contribution of immunohistochemistry to diagnostic problems of human cerebral tumors. J Histochem Cytochem 26 (7): 513-522.
23. de Armond SJ, Eng LF, Rubinstein LJ, (1980) The application of glial fibrillary acidic (GFA) protein immunohistochemistry in neurooncology. A progress report. Pathol Res Pract 168 (4): 374-394.
24. Hober S, Uhlen M, (2008) Human protein atlas and the use of microarray technologies. Curr Opin Biotechnol 19 (1): 30-35.
25. Hobera S, Uhlén M, (2008) HPA. 2008(JULY).
26. Gertler SZ, MacDonald D, Goodyear M, Forsyth P, Stewart DJ, et al. (2000) NCIC-CTG phase II study of gemcitabine in patients with malignant glioma (IND.94). Ann Oncol 11 (3): 315-318.
27. Weller M, Streffer J, Wick W, Kortmann RD, Heiss E, et al. (2001) Preirradiation gemcitabine chemotherapy for newly diagnosed glioblastoma. A phase II study. Cancer 91 (2): 423-427.
28. Wick W, Hermisson M, Kortmann RD, Kuker WM, Duffner F, et al. (2002) Neoadjuvant gemcitabine/treosulfan chemotherapy for newly diagnosed glioblastoma: A phase II study. J Neurooncol 59 (2): 151-155.
29. Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, et al. (2006) DrugBank: A comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res 34 (Database issue): D668-72.
30. Hu J, Wright FA, (2007) Assessing differential gene expression with small sample sizes in oligonucleotide arrays using a mean-variance model. Biometrics 63 (1): 41-49.